# Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Males (Drug Interaction Study and Preliminary Regimen-Finding Study)

> **NCT04481789** · PHASE1 · COMPLETED · sponsor: **Tanabe Pharma Corporation** · enrollment: 84 (actual)

## Conditions studied

- Healthy Adult Subjects

## Interventions

- **DRUG:** MT-1186
- **DRUG:** Rosuvastatin
- **DRUG:** Sildenafil
- **DRUG:** Furosemide

## Key facts

- **NCT ID:** NCT04481789
- **Lead sponsor:** Tanabe Pharma Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-17
- **Primary completion:** 2018-12-20
- **Final completion:** 2019-01-08
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2026-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04481789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04481789, "Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Males (Drug Interaction Study and Preliminary Regimen-Finding Study)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04481789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*